America’s Vaccine-Centric Strategy to Overcome SARS-CoV-2 Failing While Adequate Universal Testing & Data Collection ‘Grossly Inadequate’

America's Vaccine-Centric Strategy to Overcome SARS-CoV-2 Failing While Adequate Universal Testing & Data Collection 'Grossly Inadequate'

One of the most influential physicians and researchers in America declared recently that a "vaccine-centric" strategy has precluded important other strategies in the war against COVID-19, such as pervasive, ubiquitous testing as well as relevant data collection. They don't get much smarter or revered than Dr. Eric Topol, an outspoken, honest—and brilliant—founder of the Scripps Research Translational Institute. Nominated as one of America's most influential physician leaders by Modern Healthcare, Dr. Topol has published over 1,200 entries in peer review journals, authored three best-selling books, and frequently communicated on the challenges of COVID-19. With a large and loyal following, Topol's known for his reputation for objectivity and candor, making him a favorite of scientists who appreciate his independence. Considered trustworthy in a special influence-driven age, Topol's recent critical assessment of the most recent delta variant-driven surge suggests, "America is flying in the blind when it comes to the delta variant." The lack of pervasive testing and proper data collection makes the pandemic far worse for America, suggests Topol. With growing virulent, ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee